Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients

Journal of the American Society of Nephrology

Volumn 18, Issue 4, 2007, Pages 1331-1337

  Johnston, Olwyn ^a   Zalunardo, Nadia ^a   Rose, Caren ^a   Gill, John S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIALYSIS; FEMALE; GRAFT FAILURE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SEPTICEMIA; SURVIVAL; UNITED STATES; VASCULAR ACCESS;

EID: 34047241603     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006091017     Document Type: Article

References (27)

1. Gill JS, Abichandani R, Khan S, Kausz AT, Pereira BJ: Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 61: 2193-2200, 2002
2. Ojo A, Wolfe RA, Agodoa LY, Held PJ, Port FK, Leavey SF, Callard SE, Dickinson DM, Schmouder RL, Leichtman AB: Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analyses from the United States Renal Data System. Transplantation 66: 1651-1659, 1998
3. Gill JS, Abichandani R, Kausz AT, Pereira BJ: Mortality after kidney transplant failure: The impact of non-immunologic factors. Kidney Int 62: 1875-1883, 2002
4. Arias M, Escallada R, de Francisco AL, Rodrigo E, Fernandez-Fresnedo G, Setien MA, Pinera C, Ruiz JC, Herraez I, Cotorruelo J: Return to dialysis after renal transplantation. Which would be the best way? Kidney Int Suppl 80: 85-88, 2002
5. Meier-Kriesche HU, Kaplan B: Death after graft loss: A novel endpoint for renal transplantation. Transplant Proc 33: 3405-3406, 2001
6. Kaplan B, Meier-Kriesche HU: Death after graft loss: An important late study endpoint in kidney transplantation. Am J Transplant 2: 970-974, 2002
7. Knoll G, Muirhead N, Trpeski L, Zhu N, Badovinac K: Patient survival following renal transplant failure in Canada. Am J Transplant 5: 1719-1724, 2005
8. USRDS: US Renal Data System 2005 Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005
9. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58: 1758-1764, 2000
10. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ: Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 15: 1038-1045, 2004
11. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
12. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158-165, 1996
13. Quaschning T, Mainka T, Nauck M, Rump LC, Wanner C, Kramer-Guth A: Immunosuppression enhances atherogenicity of lipid profile after transplantation. Kidney Int Suppl 71: S235-S237, 1999
14. Caillard S, Agodoa LY, Bohen EM, Abbott KC: Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: Characteristics, risk factors and prognosis. Transplantation 81: 888-895, 2006
15. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 4: 905-913, 2004
16. Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int 68: 311-318, 2005
17. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in US hemodialysis patients. Kidney Int 60: 1443-1451, 2001
18. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999
19. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19: 214-234, 1992
20. Abbott KC, Agodoa LY: Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 56: 124-131, 2001
21. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: EPIBAC-DIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9: 869-876, 1998
22. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266, 2002
23. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL: Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44: 22-26, 2004
24. Port FK, Eknoyan G: The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): A cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis 44: 1-6, 2004
25. Hariharan S: Recommendations for outpatient monitoring of kidney transplant recipients. Am J Kidney Dis 47: S22-S36, 2006
26. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR: The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 1[Suppl 2]: 3-95, 2001
27. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11: 520-529, 2000